Agree. I'm not putting any negativity towards the company at all (except my dig at the wording on the evaluation of our - as I see it - underperforming distributors).
Simply trying to put some guesswork into the timing of the InVivage getting to market. But as you said, the company has foreseen the enormity of the job of getting approvals for all the devices and put what appears excellent people in the States to maximise success and efficiency for the FDA process. They can't know yet how long the Invivage process is going to take, but my guess is again, it will not be till 2026 with the setback with fluorescein.
Ann: OIL March 2024 Quarterly Report and Appendix 4C, page-15
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $142.0M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 16.0¢ | $61.96K | 364.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 71207 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 74991 | 3 |
View Market Depth
| Last trade - 16.10pm 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
16.5¢ |
Change
-0.005 ( 3.90 %) |
||||
| Open | High | Low | Volume | ||
| 17.5¢ | 17.5¢ | 16.0¢ | 85865 | ||
| Last updated 15.56pm 12/06/2024 ? | |||||
| OIL (ASX) Chart |